444 related articles for article (PubMed ID: 8209669)
21. Update on the medical treatment of endometriosis.
Minjarez DA; Schlaff WD
Obstet Gynecol Clin North Am; 2000 Sep; 27(3):641-51. PubMed ID: 10958009
[TBL] [Abstract][Full Text] [Related]
22. Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Ishihara H; Kiyomizu M; Honjo H
Fertil Steril; 2008 Jun; 89(6):1831-5. PubMed ID: 17761178
[TBL] [Abstract][Full Text] [Related]
23. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
24. Medical treatment of endometriosis.
Simón C; García-Velasco J
Gynecol Obstet Invest; 2004; 57(1):51-2. PubMed ID: 14974458
[No Abstract] [Full Text] [Related]
25. Endometriosis: clinical assessment and medical management.
Stockwell J
Adv Nurse Pract; 2006 Jan; 14(1):43-5. PubMed ID: 16425515
[No Abstract] [Full Text] [Related]
26. Add-back therapy use and its impact on LA persistence in patients with endometriosis.
Fuldeore MJ; Marx SE; Chwalisz K; Smeeding JE; Brook RA
Curr Med Res Opin; 2010 Mar; 26(3):729-36. PubMed ID: 20092387
[TBL] [Abstract][Full Text] [Related]
27. GnRH analogues in the treatment of endometriosis.
Erickson LD; Ory SJ
Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
[TBL] [Abstract][Full Text] [Related]
28. [Endometriosis in adolescence - treatment].
Tsenov D
Akush Ginekol (Sofiia); 2000; 40(4):26-8. PubMed ID: 11288628
[TBL] [Abstract][Full Text] [Related]
29. "Add-back" therapy for endometriosis in adolescents.
Lubianca JN; Gordon CM; Laufer MR
J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
[TBL] [Abstract][Full Text] [Related]
30. Alendronate for the prevention of bone mineral loss during gonadotropin-releasing hormone agonist therapy.
Ripps BA; VanGilder K; Minhas B; Welford M; Mamish Z
J Reprod Med; 2003 Oct; 48(10):761-6. PubMed ID: 14619641
[TBL] [Abstract][Full Text] [Related]
31. Steroidal drugs in endometriosis.
Kauppila AJ; Telimaa S; Rönnberg L
Acta Obstet Gynecol Scand Suppl; 1989; 150():7-13. PubMed ID: 2533450
[TBL] [Abstract][Full Text] [Related]
32. [Effect of GnRH analogues on bone density in the vertebral column and the femur].
Perrone G; Galoppi P; Critelli C; Bazzoffi R; Capri O; Barillaro F; Zichella L
Minerva Ginecol; 1995 Oct; 47(10):461-5. PubMed ID: 8559437
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacotherapy for pelvic endometriosis in women].
Starczewski A; Brodowska A; Brodowski J
Pol Merkur Lekarski; 2009 Mar; 26(153):231-3. PubMed ID: 19388539
[TBL] [Abstract][Full Text] [Related]
34. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
35. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin.
Dawood MY; Ramos J; Khan-Dawood FS
Fertil Steril; 1995 Jun; 63(6):1177-83. PubMed ID: 7750585
[TBL] [Abstract][Full Text] [Related]
36. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
Greenwald MW; Gluck OS; Lang E; Rakov V
Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
[TBL] [Abstract][Full Text] [Related]
37. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.
Sagsveen M; Farmer JE; Prentice A; Breeze A
Cochrane Database Syst Rev; 2003; 2003(4):CD001297. PubMed ID: 14583930
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
[TBL] [Abstract][Full Text] [Related]
39. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
DiVasta AD; Feldman HA; Sadler Gallagher J; Stokes NA; Laufer MR; Hornstein MD; Gordon CM
Obstet Gynecol; 2015 Sep; 126(3):617-627. PubMed ID: 26181088
[TBL] [Abstract][Full Text] [Related]
40. [Limited effect of gonadotrophin-releasing hormone analogues for patients with endometriosis].
Seyer-Hansen M; Kruse C
Ugeskr Laeger; 2012 Jun; 174(24):1671-3. PubMed ID: 22681992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
